Worthington Steel, Inc. reports company news centered on value-added steel processing, quarterly and annual operating results, dividends, conference calls and corporate updates. Its business updates describe carbon flat-rolled steel processing, electrical steel laminations, tailor welded products and related capabilities such as galvanizing, pickling, configured blanking, specialty cold reduction and lightweighting.
Worthington Steel news also includes disclosures about material agreements, capital-structure matters and shareholder-related developments when they affect the company’s public reporting. The recurring news record reflects a NYSE-listed Ohio company with steel-processing operations across the United States and international markets.
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) will report its financial results for the fourth quarter and full year ended December 31, 2022, after market close on February 13, 2023. A conference call will follow at 4:30 p.m. ET for management to discuss the results. Investors can join by calling +1 (646) 904 5544 domestically or +1 (929) 526 1599 internationally. The company develops advanced surgical robotics aimed at improving the efficiency of procedures and reducing costs, using proprietary technology to perform minimally invasive surgeries.
Summary not available.
Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) announced a significant expansion at Dallas's Addison Airport (ADS), doubling its footprint to approximately 195,000 rentable square feet. The CEO, Tal Keinan, highlighted Dallas as a key market for business jets, enhancing the airport's attractiveness for private and corporate flight departments. Sky Harbour operates campuses at Houston's Sugar Land Regional Airport and Nashville International Airport, with a Miami campus set to open soon. New facilities are also in development at Denver Centennial and Phoenix Deer Valley Airports.
ROSS Acquisition Corp II (NYSE: ROSS,WS) has entered into a definitive agreement to merge with APRINOIA Therapeutics, a clinical-stage biotech focused on neurodegenerative diseases. The transaction is valued at $280 million, with funding aimed at advancing APRINOIA's therapeutic programs, including its lead product, APN-1607. The merger, expected to close in the first half of 2023, will create a publicly traded entity on Nasdaq or NYSE. APRINOIA holds agreements with major biotech firms such as Biogen, and anticipates significant market opportunities in treating Alzheimer’s Disease, which affects an estimated 10 million individuals in China alone.
Ares Acquisition Corporation (NYSE: AAC) announced the postponement of its extraordinary general meeting of shareholders from January 24, 2023, to February 2, 2023, at 9:30 a.m. ET. The meeting will address the Extension Amendment Proposal, which seeks to extend the deadline for completing a business combination from February 4, 2023, to August 4, 2023. The proposal also aims to remove restrictions on share repurchases and the minimum net tangible assets requirement. Additionally, the deadline for shareholders to submit redemption requests has been extended to January 31, 2023. Shareholders of record as of December 15, 2022, are eligible to vote.
Golden Falcon Acquisition Corp. (GFX) announced the adjournment of its Special Meeting originally scheduled for December 16, 2022, to December 20, 2022. The meeting aims to vote on four proposals, including an amendment to extend the deadline for completing a business combination to June 22, 2023. Other proposals include re-electing two board directors and ratifying their independent auditor for fiscal 2022. Stockholders are encouraged to submit or change their proxies ahead of the meeting, which remains open for questions via their proxy solicitor.
Graf Acquisition Corp. IV (NYSE: GFOR) has withdrawn its Extension Proposal to delay the deadline for a business combination from May 25, 2023 to September 29, 2023. This decision comes ahead of the special stockholder meeting scheduled for December 21, 2022. Consequently, shareholders will not have the option to redeem shares for a pro rata portion of the trust account funds. Shares already submitted for redemption will be returned promptly. The withdrawal does not affect three other proposals on the ballot.
On December 14, 2022, Longview Acquisition Corp. II's stockholders approved amendments to its Charter and Investment Trust Management Agreement. The amendments extend the deadline for completing a business combination to September 23, 2023. Following the amendments, stockholders redeemed 60,932,798 Public Shares for around $612.98 million, leaving 8,067,202 shares outstanding. The company plans to redeem all remaining Public Shares due to an inability to finalize a business combination by the new deadline and will begin the liquidation process. The securities are expected to be delisted from NYSE.
Volta Inc. (NYSE: VLTA, VLTA WS) has received notice from the NYSE for non-compliance with listing standards due to its Class A Common Stock averaging below $1.00 for 30 consecutive trading days. The company can regain compliance within six months if the stock closes above $1.00 for a sufficient period. Volta aims to notify the NYSE of its intention to cure this deficiency by December 8, 2022, and may pursue a reverse stock split subject to shareholder approval at the next annual meeting. The stock will remain listed during this correction period.
Volta reported a strong third quarter, with revenue increasing 69% year-over-year to $14.4 million. Notably, media revenue reached a record $12.2 million, reflecting a 66% year-over-year increase. The network of installed charging stalls grew by 173 to 3,093 stalls, marking a 45% rise year-over-year. Volta significantly reduced SG&A expenses by 43%, with a 54% cut in U.S. headcount. The company continues to align with federal initiatives to deploy EV infrastructure and expand its digital advertising business, leveraging its extensive media network.